Education and Professional Standing
- MSc Design, Measurement & Evaluation, McMaster University, 1997
- FRCPC Medical Microbiology, 1988
- FRCPC Infectious Diseases, 1987
- FRCPC Internal Medicine, 1985
- FRACP General Medicine, 1984
- MBChB, Otago University (New Zealand) 1978
Main Research Areas
- HIV infection
- infections in immunocompromised hosts
- diagnostic medical microbiology
- infection control
- infections in pregnancy
- clinical epidemiology
Dr. Smaill is actively involved in clinical trials in HIV management, the development of vaccines for tuberculosis, and management of infections in pregnancy. Her interest in HIV infection includes multicentre trials to evaluate efficacy and side-effects of different antiretroviral regimens and work on gender differences in the management of HIV infection. Dr. Smaill is also working with Dr. Xing on an adenovirus-based vaccine for tuberculosis and has completed a successful Phase 1 clinical trial in healthy volunteers demonstrating the safety and immunogenicity of novel TB vaccine.
Dr. Smaill has an ongoing commitment to complete and update several Cochrane Systematic Reviews related to the management of infections in pregnancy, with a focus on treatment of asymptomatic bacteriuria and antibiotic prophylaxis for cesarean sections.
Dr. Smaill is a medical microbiologist for the Hamilton Regional Laboratory Medicine Program,and consultant in infectious diseases and infection control and the research lead of the HIV clinic at Hamilton Health Sciences.
Dr. Smaill is a professor of Pathology and Molecular Medicine. She currently teaches in McMaster’s MD Undergraduate Program, the MD Postgraduate Program and in the Medical Sciences Graduate Program.
Laura Puri – Research Coordinator